Decision is a boon for the mRNA-vaccine maker in its legal fight to recoup pandemic profits from rivals

WTVB

Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot

According to its own statements, the US biotech company Moderna has won a case before the European Patent Office in a dispute with rivals Pfizer and Biontech over its corona vaccine. The European Patent Office had decided to maintain the validity of Moderna's EP949 patent. It is assumed that the rivals would appeal against this. Pfizer and Biontech did not initially comment. Just one of several patent disputes, this is one of several patent disp…

Das US-Biotech-Unternehmen Moderna hat nach eigenen Angaben im Streit mit den Rivalen Pfizer und Biontech um seinen Corona-Impfstoff einen Fall vor dem Europäischen Patentamt gewonnen.  Das Europäische Patentamt habe entschieden, die Gültigkeit des Patents EP949 von Moderna aufrechtzuerhalten. Man gehe davon aus, dass die Rivalen dagegen Berufung einlegen würden. Pfizer und Biontech gaben zunächst keine Stellungnahme ab.Bloß eine von mehreren Pa…

Moderna gewinnt Patentstreit gegen Biontech/Pfizer

Media Bias/Fact Check

Kronen Zeitung

Vienna

Austria

Moderna wins patent dispute against Biontech/Pfizer

Pfizer said it was disappointed and would consider all legal options and may appeal the decision

Ad Fontes Media

All Sides

The Globe & Mail

The Woodbridge Company

Canada

Moderna wins patent case in Europe against Pfizer, BioNTech over COVID shot

The US biotech company achieved partial success in the legal dispute with Pfizer and Biontech.

Das US-Biotech Unternehmen erringt einen Teilerfolg im Rechtsstreit mit Pfizer und Biontech.

Streit um Corona-Impfstoff: Moderna gewinnt gegen Biontech und Pfizer

Kurier

Funke Mediengruppe

Corona vaccine dispute: Moderna wins against Biontech and Pfizer

(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the company said on Friday. “We are pleased to announce that the European Patent Office decided to maintain the validity of Moderna’s EP949 patent, one of the key patents currently asserted against Pfizer and BioNTech in various European national courts,” Moderna said in an emailed statement. The company said it expe…

Midwest Communications

Moderna, an American pharmaceutical company involved in the research and development of new drugs and vaccines, has won a dispute with the European Patent Office (EPO) with the rival Pfizer/BioNTech consortium over the patent of an mRNA method for the use of its Covid-19 vaccine. However, the verdict of the court is not final. The information was reported by Reuters.

Americká farmaceutická společnost Moderna, která se zabývá výzkumem a vývojem nových léčiv a vakcín, vyhrála u Evropského patentového úřadu (EPO) spor s konkurenčním konsorciem Pfizer/BioNTech ohledně patentu metody mRNA pro používání své vakcíny proti covidu-19.  Verdikt soudu však není pravomocný. Informaci přinesla agentura Reuters.

Moderna vyhrála spor s Pfizerem a BioNTechem kvůli vakcíně proti covidu

Novinky.cz

Seznam.cz

Moderna wins lawsuit with Pfizer and BioNTech over covid vaccine

Financial Times

Nikkei Inc.

London

Greater London

England

United Kingdom

Moderna wins Covid jab patent dispute over Pfizer and BioNTechFinancial Times

FRANKFURT/CAMBRIDGE/NEW YORK. According to its own statements, the US biotech company Moderna has won a case before the European Patent Office in a dispute with rivals Pfizer and Biontech over its corona vaccine.

FRANKFURT/CAMBRIDGE/NEW YORK. Das US-Biotech-Unternehmen Moderna hat nach eigenen Angaben im Streit mit den Rivalen Pfizer und Biontech um seinen Corona-Impfstoff einen Fall vor dem Europ�ischen Patentamt gewonnen.

Moderna wins Covid jab patent dispute over Pfizer and BioNTechFinancial Times

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics